MCE - Delayed Quote EUR
Atrys Health, S.A. (ATRY.MC)
At close: 5:35 PM GMT+2
Research Analysis
Revenue vs. Earnings
Revenue 54.68M
Earnings -8.24M
Analyst Price Targets
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | |
---|---|
EPS Est. | -- |
EPS Actual | -- |
Difference | -- |
Surprise % | -- |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ATRY.MC | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 3.10% |
Next Qtr. | -- | -- | -- | 8.00% |
Current Year | -- | -- | -- | 2.30% |
Next Year | -- | -- | -- | 13.20% |
Next 5 Years (per annum) | -- | -- | -- | 11.85% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
ORY.MC Oryzon Genomics S.A.
1.7420
-1.58%
SVA Sinovac Biotech Ltd.
6.47
0.00%
PHM.MC Pharma Mar, S.A.
72.05
+3.22%
AUTL Autolus Therapeutics plc
4.4400
-1.77%
FATE Fate Therapeutics, Inc.
3.1900
+1.27%
TRVN Trevena, Inc.
1.9900
+1.02%
ATYR aTyr Pharma, Inc.
3.3500
+2.76%
CANF Can-Fite BioPharma Ltd.
2.8200
-3.75%
VRAX Virax Biolabs Group Limited
1.6800
+3.07%
XERS Xeris Biopharma Holdings, Inc.
3.0200
-0.33%